Using Apremilast to help treat alcohol use disorder
Official title: APREMILAST FOR THE TREATMENT OF ALCOHOL USE DISORDER -- CONTRACT RESEARCH ORGANIZATION STUDY AND DATA MANAGEMENT
Funded at Fast Track Drugs and Biol · NIH-11218300 · Data updated 2026-11-12
This study is looking at how well the medication Apremilast can help people with alcohol use disorder, and if you join, you'll receive the treatment while being carefully monitored to see how it works for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fast Track Drugs and Biol NIH-funded |
| Lab location | 1 site (Gaithersburg, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2026 |
| Funding year | 2024 |
| Award (this year) | $5,811,442 |
| NIH project number | 75N94019D00001-0-759402400002-1 |
| Project ID | NIH-11218300 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with alcohol use disorder who are seeking treatment.
✕Less likely to help
Patients who do not have alcohol use disorder or those who are currently undergoing other forms of treatment may not benefit from this research.
What this research studies
This research focuses on the use of Apremilast, a medication, to treat individuals with alcohol use disorder (AUD). The study involves a Contract Research Organization (CRO) that will coordinate and support clinical trials across various research sites. Patients participating in this research may receive the medication while being closely monitored for safety and effectiveness, with data collected to assess the treatment's impact. The CRO will handle all aspects of the trial, including regulatory support, data analysis, and preparation of study reports.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for individuals struggling with alcohol use disorder.
How similar studies have gone: Previous research has shown promise in using medications for treating alcohol use disorder, making this approach a continuation of established methods.
Where this research is happening
-
Fast Track Drugs and Biol
Gaithersburg, United States Active
Researchers
- Principal investigator: Ransom, Janet — Fast Track Drugs and Biol
- Study coordinator: Ransom, Janet
Related research
Other NIH-funded projects on the same topics.
-
Functional Connectivity-Guided TMS for Alcohol Use Disorder
A new approach uses targeted brain stimulation to help people with alcohol use disorder stay abstinent longer by focusing treatment on specific brain circuits.
-
Alcohol Use Disorder and Suicidal Behavior: Finding Why They Occur Together
A study using Swedish population data to understand why alcohol use disorder relates to suicidal thoughts and acts, with the goal of improving risk prediction and prevention.
-
Non-hallucinogenic psilocybin derivative for alcohol use disorder
A new, safer psilocybin-like compound is being studied to help people with alcohol use disorder.
-
Identifying brain proteins linked to PTSD and alcohol use disorder
Researchers are studying brain proteins that may contribute to PTSD and alcohol use disorder in US veterans to find new ways to help people who struggle with both conditions.
-
Mu and Kappa Opioid Balance in Alcohol Use Disorder
A study using brain imaging to understand how the brain’s opioid system changes during early sobriety in adults with alcohol use disorder.
-
Telehealth support to prevent suicide in people with alcohol use disorder in Tanzania
A telehealth counseling program is being adapted to help reduce suicide risk for people with alcohol use disorder in emergency departments in Tanzania.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.